Vertex Pharmaceuticals Incorporated Highlights Telaprevir Progress and Reports Second Quarter 2008 Results

August 1, 2008 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported recent clinical progress and consolidated financial results for the quarter ended June 30, 2008.

Twitter
LinkedIn
Facebook
Email
Print

Earnings